The management of scarring after thyroid cancer: from medical principles to clinical guidelines
Pathological mechanisms of scarring after thyroid cancer
The process of thyroid cancer, which usually requires a neck cut to clear the stove and lymphoma, activates the mechanism for repair of skin tissue. Fibre cell proliferation, gelatin deposition and inflammation responses are co-involved in the formation of scars, in which the abnormal activation of the transformation factor-beta signal flow is a key factor leading to rational scarring of the disease (e. G. Amplified scars, oscillations). Clinical statistics show that about 23 per cent of patients with thyroid cancer experience a significant increase in scarring, which is closely related to surgical oral tension, individual body and post-operative care. The central role of scar cream as the basis for post-operative scar treatment is to regulate the healing micro-environment of the wound, inhibit the excessive growth of fibre cells and promote the orderly placement of glued proteins。
Clinical selection criteria for scarring after thyroid cancer
The scarring after thyroid cancer, which is currently used in clinical practice, is divided into three main categories: silicone, heparin and chinese combinations. Silicone-type formulations (e. G., medical silicone gels) that reduce the evaporation of skin water through the formation of hydrate membranes and reduce scar tissue tension are first-line anti-scarb drugs approved by fda in the united states, applicable to acute interventions of 0-3 months after thyroid cancer. Hepatin-like products (e. G., psulfate sticky mascara) can inhibit inflammation of inflammation cells, improve local blood circulation, and have a significant effect on red-swollen scars associated with thyroid cancer. The chinese medicine scarring ointment (e. G. Snow cream ointment) works by inhibiting fibrous cell activity and is more suitable for the long-term reconciliation of the post-prospective thyroid cancer period. Clinical practice has shown that the combined use of silica and heparin scarlet can increase post-magnetic scar improvement to 78 per cent, significantly better than a single drug programme。
Standardized use of scar cream after thyroid cancer
The use of scar cream after thyroid cancer is subject to the "3-stage incremental" principle: five to seven days after the operation, two times a day, evenly covering the entire surgical cut and the 2 cm range around it, with a light massage to full absorption. Within one month of the thyroid cancer (acute inflammation period), lighter silicone gels should be selected to avoid stimulating fresh creation; after the surgery, between one and three months (increasing period) can be replaced with anti-inflammatory hepatin formulations; and after the surgery, more than three months (incredient period) are recommended to maintain the efficacy of the treatment with scar cream with a moist component. Particular attention is paid to ensuring that patients with thyroid cancer are fully healed before they are painted with scar cream, and that they should be suspended immediately in case of skin allergies or fractures and consulted with the attending physician. Clinical studies have confirmed that the standardized use of scar cream can lead to an average reduction of 42 per cent in the thickness of the thyroid cancer and an improvement of 65 per cent in pigmentation。
Integrated management strategy for scar management after thyroid cancer
The sole use of scar cream is difficult to fully meet the need for post-terrestrial cancer scar resistance and requires a combination of stress therapy and laser therapy. A tailored neck-pressure-and-bullet condom can be worn for 12-16 hours per day two weeks after the thyroid cancer, and the growth of scars can be inhibited by continuous stress, with synergy from use with scar cream. For visible scars that remain six months after the thyroid cancer, 595 nm pulsed dye lasers can be used to destroy over-emerging carcasses and to promote the remodelling of gelatine fibres. With regard to nutritional support, patients with thyroid cancer should increase their intake of high-quality protein (e. G. Fish, eggs) and vitamin c to provide raw materials for scar repair. Psychological intervention is equally important, as scarring after thyroid cancer can lead to psychological problems such as social recusal, combined with cognitional behaviour therapy with scar cream treatment, which can significantly improve the quality of life of patients。
Common misdialysis of scarring after thyroid cancer
Clinical thyroid cancer patients often suffer from three major errors in the use of scar cream: first, "the sooner the effect is done", while thyroid cancer requires the complete skinification of the mouth (usually three to five days after the line is removed) before it can be used, and early use can cause infection; second, "the greater the effect, the greater the use", with excessive smearing not only causes waste, but also impedes skin breathing, but rather slows post-molecular healing; and third, "long-term single use", neglects the pathological characteristics of the scars at different stages after thyroid cancer, resulting in poor post-treatment. The latest clinical guide makes it clear that the management of the post-hysterectomy scar should follow the dynamic assessment-adaptation model, whereby every four weeks a specialist assesses the state of the scar and adjusts the type of scar cream and frequency of its use, and this individualization can lead to a 35 per cent improvement in the success of the post-hysterectomy scar。
Evidence-based medical evidence for the treatment of post-circular scars
A multi-centre study published in the chinese surgery journal in 2023 showed that the standardized use of scar cream after thyroid cancer for six months could reduce the vancouver scar table (vss) rating by 5. 2 points, and that the efficacy of silica-like scar cream was not influenced by the age, sex and surgical manner of the patient. Another random cross-checking test, which included 326 cases of thyroid cancer, confirmed that the quality of life rating (sbses) associated with scarring continued to be significantly higher (78. 5 vs. 56. 3 points) for patients who continued to use scar cream during the first year of the operation. It is worth noting that there are individual differences in the effect of scar cream after thyroid cancer, and that patients with placards are required to extend their treatment cycle to more than 12 months and, where necessary, co-injected with local sugar cortex hormone treatment. There is currently no evidence that scar cream affects tsh inhibition treatment for thyroid cancer patients, and there is no apparent interaction of drugs in clinical applications。
Future prospects for the management of scar management after thyroid cancer
With the development of precision medical techniques, post-circular scar cream is moving in the direction of treatment to the genetic target, and new smart scar creams can be individualized by detecting the release of drugs at the ph of skin. Clinical studies have shown that the new scar ointment type injected in combination with the blood-rich plate plasma (prp) has reduced the recovery time for thyroid cancer to one third of traditional treatment. In the future, post-circular scar management will form a new triple model of "preventive-therapeutic-prospecting", with scar cream as a primary treatment, the clinical value of which will be further enhanced by multidisciplinary joint treatment. After the thyroid cancer, a scientific concept of scar management should be developed and the use of scar cream should be regulated under the guidance of a professional physician to obtain the best possible restoration of the neck appearance。
